Phase III Study of TY-9591 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLETEO)

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(2 sites)

China

Hunan Provincial Tumor Hospital, Changsha, Hunan

Shanghai Chest Hospital, Shanghai, Shanghai Municipality